Neural Stem Cell Transplantation And Myelination: Results Of A Phase I Trial In Pelizaeus-Merzbacher Disease

被引：0
|
作者：
Gupta, Nalin
Henry, Roland
Strober, Jonathan
Kang, Sang-Mo
Lim, Daniel
Bucci, Monica
Caverzasi, Eduardo
Gaetano, Laura
Mandelli, Maria
Ryan, Tamara
Perry, Rachel
Farrell, Jody
Jeremy, Rita
Ulman, Mary
Huhn, Stephen
Barkovich, James
Rowitch, David
机构：
来源：
JOURNAL OF NEUROSURGERY | 2013年 / 119卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A566 / A566
页数：1
相关论文
共 50 条
  • [21] Patient-derived iPS cells for unveiling the molecular pathology of Pelizaeus-Merzbacher disease: a commentary on 'Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication'
    Inoue, Ken
    JOURNAL OF HUMAN GENETICS, 2012, 57 (09) : 553 - 554
  • [22] PELIZAEUS-MERZBACHER DISEASE, CLASSICAL TYPE-I - CLINICAL AND ULTRASTRUCTURAL-STUDY OF CENTRAL AND PERIPHERAL NERVOUS SYSTEMS
    BORNHOFEN, JH
    ARAOZ, C
    SUN, CN
    CLINICAL RESEARCH, 1978, 26 (01): : A81 - A81
  • [23] Human Fetal Neural Stem Cell Transplantation for ALS: A Phase I Safety Trial
    Federici, T.
    Riley, J.
    Johe, K.
    Freeman, T.
    Feldman, E.
    Glass, J.
    Boulis, N.
    CELL TRANSPLANTATION, 2010, 19 (03) : 338 - 339
  • [24] Development of speech and hearing of two children with Pelizaeus-Merzbacher disease presenting only waves I and II of the auditory brainstem response
    Rikitake, Masahiro
    Kaga, Kimitaka
    ACTA OTO-LARYNGOLOGICA, 2012, 132 (05) : 563 - 569
  • [25] RESULTS RELEASED FOR PHASE I TRIAL OF STEM CELL TREATMENT FOR BATTEN DISEASE
    不详
    STEM CELLS TRANSLATIONAL MEDICINE, 2013, 2 (12) : XIV - XIV
  • [26] Modulation of the Innate Immune Response by Human Neural Precursors Prevails over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model of Pelizaeus-Merzbacher Disease
    Marteyn, Antoine
    Sarrazin, Nadege
    Yan, Jun
    Bachelin, Corinne
    Deboux, Cyrille
    Santin, Mathieu D.
    Gressens, Pierre
    Zujovic, Violetta
    Baron-Van Evercooren, Anne
    STEM CELLS, 2016, 34 (04) : 984 - 996
  • [27] Patient-derived iPS cells for unveiling the molecular pathology of Pelizaeus-Merzbacher disease: a commentary on ‘Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus–Merzbacher disease patient with a partial PLP1 duplication’
    Ken Inoue
    Journal of Human Genetics, 2012, 57 : 553 - 554
  • [28] Romiplostim in Patients Undergoing Allogeneic Stem Cell Transplantation: Results of a Phase I/II Multicenter Trial
    de Latour, Regis Peffault
    Chevret, Sylvie
    Ruggeri, Annalisa
    Suarez, Felipe
    Souchet, Laetitia
    Michonneau, David
    de Fontbrune, Flore Sicre
    Coman, Tereza
    t Rubio, Marie
    Nguyen, Stephanie
    Mohty, Mohamad
    Socie, Gerard
    BLOOD, 2016, 128 (22)
  • [29] Standardized cultivation and transplantation of limbal stem cell grafts: Results of a phase I/II clinical trial
    Zakaria, Nadia
    Possemiers, Tine
    Leysen, Inge
    Rozema, Jos
    Koppen, Carina
    Berneman, Zwi
    Tassignon, Marie-Jose
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [30] Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication
    Shimojima, Keiko
    Inoue, Takahito
    Imai, Yuki
    Arai, Yasuhiro
    Komoike, Yuta
    Sugawara, Midori
    Fujita, Takako
    Ideguchi, Hiroshi
    Yasumoto, Sawa
    Kanno, Hitoshi
    Hirose, Shinichi
    Yamamoto, Toshiyuki
    JOURNAL OF HUMAN GENETICS, 2012, 57 (09) : 580 - 586
12345